<DOC>
	<DOCNO>NCT01581853</DOCNO>
	<brief_summary>Lopinavir/ritonavir monotherapy currently well know widely use strategy , Lopinavir/ritonavir 800/200 mg day triple-therapy approve year ago . The purpose study evaluate efficacy safety Lopinavir/ritonavir 800/200 mg monotherapy day .</brief_summary>
	<brief_title>Pilot Simplification Study Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<criteria>Patients old 18 , HIV positive Patients receive monotherapy regimen ( Lopinavir/ritonavir twice daily ) last 6 month Undetectable viral load ( &lt; 40 copies/ml ) last 6 month Patients accept participation study sign Informed Consent Form Childbearing female negative pregnancy test use appropriate contraceptive measure Opportunistic disease , cancer active disease specific treatment Active addiction illegal drug active use psychotropic drug Mental retardation diagnosis , mental dementia severe psychiatric disorder ( exclude major depression disorder solve &gt; 3 month ) Females breastfeed pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>MONOTHERAPY</keyword>
	<keyword>PILOT</keyword>
	<keyword>LOPINAVIR/RITONAVIR</keyword>
</DOC>